13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001887785
Total reported value
$22.1M
$22.1M
3 檔
57.2%
During the Q2 2025 filing period, Madrona Venture Group, LLC (CIK: 0001887785) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $22.1M across 3 reported positions.
Madrona Venture Group, LLC executed strategic sector rebalancing during Q2 2025, establishing 1 new positions while fully exiting 1 holdings and trimming 0 positions.
In terms of portfolio concentration, the top 5 core holdings (including PATH, NAUT, DNA) accounted for 57.2% of total reported equity market value during Q2 2025.
Top New Position Initiated
DNA
市值: $477.0K
Top Position Liquidated / Trimmed
SNOW
前期市值: $17.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PATH | Uipath Inc - Class A | Stock-Tech | 61.64% | -13.60% | — | |
| 2 | NAUT | Nautilus Biotechnology Inc | Stock-Other | 34.58% | +16.48% | — | |
| 3 | DNA | Ginkgo Bioworks Holdings Inc | Stock-Other | 3.78% | -2.87% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PATH | Uipath Inc - Class A | +39.7% | — | Unchanged |
| 2 | NAUT | Nautilus Biotechnology Inc | +16.4% | — | Unchanged |
| 3 | DNA | Ginkgo Bioworks Holdings Inc | +3.8% | NEW | New buy |
| 4 | SNOW | Snowflake Inc | -59.8% | EXIT | Sold out |
According to official SEC Form 13F filings, Madrona Venture Group, LLC reported a total U.S. public equity portfolio value of $22.1M across 3 disclosed positions in Q2 2025.
During Q2 2025, Madrona Venture Group, LLC's top holdings by market value included PATH (61.6%)、NAUT (34.6%)、DNA (3.8%). The largest single position, PATH, represented 61.6% of total portfolio value.
In Q2 2025, Madrona Venture Group, LLC made 2 total portfolio adjustments, initiating 1 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.